The authors are grateful to the following individuals and organisations for the following contributions: R. Bryan Rumble, MSc for reviewing and commenting on the manuscript; American Society of Clinical Oncology (ASCO) for providing members who participated in the survey and consensus group meeting; IPSEN for providing an unrestricted educational grant; however IPSEN did not have any access to the study data nor did they have any control over the final manuscript; European Association of Urology (EAU) for providing an unrestricted educational grant; however the EAU did not have any access to the data nor did they have any control over the final manuscript.Peer reviewedPostprintPostprin
Background: Innovations in treatments, imaging, and molecular characterisation in advanced prosta...
Funding support: This work is supported by the European Association of Urology Guidelines Office.Pee...
This Review was sponsored and funded by the International Society of Cancer Prevention (ISCaP), the ...
Deferred active treatment (DAT) strategies, including active surveillance and active monitoring, are...
Funding/Support and role of the sponsor: This work was supported by Movember. Acknowledgements: We g...
none69siBackground: There is uncertainty in deferred active treatment (DAT) programmes, regarding p...
ACKNOWLEDGEMENTS The authors would like to thank Peter E Clark from Atrium Health, Levine Cancer Ins...
BACKGROUND: There is uncertainty in deferred active treatment (DAT) programmes, regarding patient se...
BACKGROUND: Innovations in treatments, imaging, and molecular characterisation in advanced prostate ...
Background: Innovations in treatments, imaging, and molecular characterisation in advanced prostate ...
Background: Innovations in treatments, imaging, and molecular characterisation in advanced prostate ...
Deferred active treatment (DAT) strategies for men with localised prostate cancer have emerged as a ...
Open Access via the Elsevier Agreement We are grateful to the EAU Research Foundation for funding th...
The first St.Gallen Advanced Prostate Cancer Consensus Conference (APCCC) Expert Panel identified an...
BACKGROUND: Innovations in imaging and molecular characterisation and the evolution of new therapies...
Background: Innovations in treatments, imaging, and molecular characterisation in advanced prosta...
Funding support: This work is supported by the European Association of Urology Guidelines Office.Pee...
This Review was sponsored and funded by the International Society of Cancer Prevention (ISCaP), the ...
Deferred active treatment (DAT) strategies, including active surveillance and active monitoring, are...
Funding/Support and role of the sponsor: This work was supported by Movember. Acknowledgements: We g...
none69siBackground: There is uncertainty in deferred active treatment (DAT) programmes, regarding p...
ACKNOWLEDGEMENTS The authors would like to thank Peter E Clark from Atrium Health, Levine Cancer Ins...
BACKGROUND: There is uncertainty in deferred active treatment (DAT) programmes, regarding patient se...
BACKGROUND: Innovations in treatments, imaging, and molecular characterisation in advanced prostate ...
Background: Innovations in treatments, imaging, and molecular characterisation in advanced prostate ...
Background: Innovations in treatments, imaging, and molecular characterisation in advanced prostate ...
Deferred active treatment (DAT) strategies for men with localised prostate cancer have emerged as a ...
Open Access via the Elsevier Agreement We are grateful to the EAU Research Foundation for funding th...
The first St.Gallen Advanced Prostate Cancer Consensus Conference (APCCC) Expert Panel identified an...
BACKGROUND: Innovations in imaging and molecular characterisation and the evolution of new therapies...
Background: Innovations in treatments, imaging, and molecular characterisation in advanced prosta...
Funding support: This work is supported by the European Association of Urology Guidelines Office.Pee...
This Review was sponsored and funded by the International Society of Cancer Prevention (ISCaP), the ...